Workflow
GCM Grosvenor Raises $625 Million Structured Solution to Invest in Credit
Globenewswire· 2026-02-24 14:00
CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a leading global alternative asset management solutions provider, announced today the second close of its structured alternatives investment solution, bringing total capital commitments to $625 million. This vehicle offers investors an opportunity to access a diversified portfolio of credit secondaries investments, with flexibility to participate through equity or debt in a rated structure. With nearly 40 years of experience, GCM Grosv ...
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
Globenewswire· 2026-02-24 14:00
SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will present new data at the 2026 ASCO-GU conference supporting its Precise MRDTM (Molecular Residual Disease) Test, Prolaris® Prostate Cancer Prognostic Test and MyRisk® Hereditary Cancer Tests. These data highlight Myriad’s expanding role across the cancer care continuum, including ultra-sensitive molecular residual disease detection, prognostic stratifi ...
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Globenewswire· 2026-02-24 14:00
CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended December 31, 2025, before the market opens on Tuesday, March 10, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call to review the company’s results at 8:30 a.m. ET (5:30 a.m. PT). Conference Call & Webcast: U.S. dial-in: 877-407-0890International dial ...
Opus One Gold Corp Gets Positive Results from a Laser Induced Breakdown Spectrometry Study on Noyell Project, Zone 1 Gold Discovery
Globenewswire· 2026-02-24 14:00
NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to present positive results obtained from a Laser Induced Breakdown Spectrometry (LIBS) study from ECORE (ELEMISSION LIBS technology) on drill core recovered during its winter 2025 drilling project on Zone 1 on its 100% owned Noyell gold project, Abitibi, Quebec. This study is part of a metallurgical evalu ...
From Singapore Success to North American Solutions: Legend Robot Unveils First-of-its-Kind Mobile Spraying Fleet at CONEXPO
Globenewswire· 2026-02-24 14:00
Defining the next era of intelligent construction automation through the lens of master-grade engineering. LAS VEGAS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amidst a critical skilled labor shortage and rising construction costs in North America, Legend Robot makes its regional debut at CONEXPO-CON/AGG (Booth N12934), introducing the industry’s first "Physical AI" autonomous finishing fleet to modernize interior commercial construction. Solving the Skilled Labor Shortage with Physical AI The North Americ ...
HydroGraph Receives US EPA and UK REACH, and EU REACH Regulatory Clearances for Commercial Scale Graphene Sales Activities
Globenewswire· 2026-02-24 14:00
Key Regulatory Milestones Support Expanded Commercial Activity and Provide Framework for Scale-UpVANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that the United States Environmental Protection Agency (“EPA”) has issued a TSCA Section 5(e) Order under Premanufacture Notice (PMN) numbers P-24-0086-87 for HydroGraph’s graphene materials described as graphene, turbostratic, 3-9 layers (P-24-0086) ...
Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer
Globenewswire· 2026-02-24 14:00
Company to wind down the GOBLET gastrointestinal study to focus on registration path in the U.S. With sufficient cash on hand to execute near-term milestones, the Company expects to avoid immediate material dilution SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced that it has concluded enrollment in the GOBLET study, having generated the necessary clinical and tr ...
Hurricane Grill & Wings Debuts New Location in Lake Jackson, TX
Globenewswire· 2026-02-24 14:00
Florida-Born Wing Brand Brings Signature Wings to Greater Houston Area LOS ANGELES, Feb. 24, 2026 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc., parent company of Hurricane Grill & Wings and 17 other restaurant concepts, announces the opening of the first Hurricane Grill & Wings in the greater Houston area, and the second location for the beloved wing brand in Texas. Located in the Plantation Village shopping center, the new Lake Jackson restaurant offers guests a welcoming dining experienc ...
Air Canada Recognized as One of Canada’s Best Diversity Employers for 2026; the Eighth Time in Ten Years
Globenewswire· 2026-02-24 14:00
MONTRÉAL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Air Canada was named one of Canada's Best Diversity Employers for 2026, the eighth time in a decade the airline has received this recognition. "We’re proud to be recognized for our ongoing commitment to diversity, equity and inclusion. This award spotlights how our employees, resource groups, champions, leaders, and community partners work together to build a more fair, equitable, and inclusive future where everyone feels they belong," said Arielle Meloul-Wechsle ...
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
Globenewswire· 2026-02-24 14:00
Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular dystrophyHOPE-3 clinical study report (CSR) submitted to the U.S. Food and Drug Administration (FDA) in support of the ongoing BLA review SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that results from its Phase 3 HOPE-3 clini ...